Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Nov;92(5):2462–2468. doi: 10.1172/JCI116854

Presence of cytoplasmic factors functional in peroxisomal protein import implicates organelle-associated defects in several human peroxisomal disorders.

M Wendland 1, S Subramani 1
PMCID: PMC288431  PMID: 7693762

Abstract

Cells from patients with peroxisome-deficient disorders contain membrane ghosts devoid of most matrix contents instead of normal peroxisomes indicating that the underlying molecular defects impair the import of matrix proteins into these peroxisome ghosts. Genetic heterogeneity for the molecular defects was inferred from the assignment of patients with peroxisome-deficient disorders into nine complementation groups. The aim of our studies was to analyze cell lines from six different complementation groups in a systematic manner for the presence of peroxisome ghosts, the ability to import Ser-Lys-Leu-containing proteins into peroxisome ghosts and for the presence of cytosolic factors required for peroxisomal protein import. We show that each of the cell lines analyzed contains peroxisome ghosts, but is unable to import matrix proteins as judged by a peroxisomal import assay using permeabilized cells. The addition of wild type cytosol did not restore the capacity to import matrix proteins but cytosol prepared from these cell lines was functional in stimulation of peroxisomal protein import in a heterologous system. These results implicate organelle-associated molecular defects in each of the six cell lines analyzed.

Full text

PDF
2462

Images in this article

2464Image
on p.2464
2464Image
on p.2464
2464Image
on p.2464
2464Image
on p.2464
2465Image
on p.2465
2465Image
on p.2465
2465Image
on p.2465
2465Image
on p.2465
2466Image
on p.2466
2466Image
on p.2466
2466Image
on p.2466
2466Image
on p.2466
2466Image
on p.2466
2467Image
on p.2467
2467Image
on p.2467
2467Image
on p.2467
2467Image
on p.2467
2467Image
on p.2467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arias J. A., Moser A. B., Goldfischer S. L. Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders. J Cell Biol. 1985 May;100(5):1789–1792. doi: 10.1083/jcb.100.5.1789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balfe A., Hoefler G., Chen W. W., Watkins P. A. Aberrant subcellular localization of peroxisomal 3-ketoacyl-CoA thiolase in the Zellweger syndrome and rhizomelic chondrodysplasia punctata. Pediatr Res. 1990 Mar;27(3):304–310. doi: 10.1203/00006450-199003000-00023. [DOI] [PubMed] [Google Scholar]
  3. Danks D. M., Tippett P., Adams C., Campbell P. Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J Pediatr. 1975 Mar;86(3):382–387. doi: 10.1016/s0022-3476(75)80967-x. [DOI] [PubMed] [Google Scholar]
  4. Goldfischer S., Collins J., Rapin I., Coltoff-Schiller B., Chang C. H., Nigro M., Black V. H., Javitt N. B., Moser H. W., Lazarow P. B. Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies. Science. 1985 Jan 4;227(4682):67–70. doi: 10.1126/science.3964959. [DOI] [PubMed] [Google Scholar]
  5. Goldfischer S., Moore C. L., Johnson A. B., Spiro A. J., Valsamis M. P., Wisniewski H. K., Ritch R. H., Norton W. T., Rapin I., Gartner L. M. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 1973 Oct 5;182(4107):62–64. doi: 10.1126/science.182.4107.62. [DOI] [PubMed] [Google Scholar]
  6. Gould S. J., Keller G. A., Hosken N., Wilkinson J., Subramani S. A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol. 1989 May;108(5):1657–1664. doi: 10.1083/jcb.108.5.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gärtner J., Chen W. W., Kelley R. I., Mihalik S. J., Moser H. W. The 22-kD peroxisomal integral membrane protein in Zellweger syndrome--presence, abundance, and association with a peroxisomal thiolase precursor protein. Pediatr Res. 1991 Feb;29(2):141–146. doi: 10.1203/00006450-199102000-00007. [DOI] [PubMed] [Google Scholar]
  8. Gärtner J., Moser H., Valle D. Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome. Nat Genet. 1992 Apr;1(1):16–23. doi: 10.1038/ng0492-16. [DOI] [PubMed] [Google Scholar]
  9. Heymans H. S., Schutgens R. B., Tan R., van den Bosch H., Borst P. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature. 1983 Nov 3;306(5938):69–70. doi: 10.1038/306069a0. [DOI] [PubMed] [Google Scholar]
  10. Kamijo K., Taketani S., Yokota S., Osumi T., Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J Biol Chem. 1990 Mar 15;265(8):4534–4540. [PubMed] [Google Scholar]
  11. Moser A. E., Singh I., Brown F. R., 3rd, Solish G. I., Kelley R. I., Benke P. J., Moser H. W. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. N Engl J Med. 1984 May 3;310(18):1141–1146. doi: 10.1056/NEJM198405033101802. [DOI] [PubMed] [Google Scholar]
  12. Osumi T., Tsukamoto T., Hata S., Yokota S., Miura S., Fujiki Y., Hijikata M., Miyazawa S., Hashimoto T. Amino-terminal presequence of the precursor of peroxisomal 3-ketoacyl-CoA thiolase is a cleavable signal peptide for peroxisomal targeting. Biochem Biophys Res Commun. 1991 Dec 31;181(3):947–954. doi: 10.1016/0006-291x(91)92028-i. [DOI] [PubMed] [Google Scholar]
  13. Poulos A., Sharp P., Whiting M. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome? Clin Genet. 1984 Dec;26(6):579–586. doi: 10.1111/j.1399-0004.1984.tb01107.x. [DOI] [PubMed] [Google Scholar]
  14. Roscher A. A., Hoefler S., Hoefler G., Paschke E., Paltauf F., Moser A., Moser H. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Pediatr Res. 1989 Jul;26(1):67–72. doi: 10.1203/00006450-198907000-00019. [DOI] [PubMed] [Google Scholar]
  15. Roscher A. A., Rolinski B. Peroxisomal disorders in man. Cell Biochem Funct. 1992 Sep;10(3):201–207. doi: 10.1002/cbf.290100310. [DOI] [PubMed] [Google Scholar]
  16. Santos M. J., Hoefler S., Moser A. B., Moser H. W., Lazarow P. B. Peroxisome assembly mutations in humans: structural heterogeneity in Zellweger syndrome. J Cell Physiol. 1992 Apr;151(1):103–112. doi: 10.1002/jcp.1041510115. [DOI] [PubMed] [Google Scholar]
  17. Santos M. J., Imanaka T., Shio H., Lazarow P. B. Peroxisomal integral membrane proteins in control and Zellweger fibroblasts. J Biol Chem. 1988 Jul 25;263(21):10502–10509. [PubMed] [Google Scholar]
  18. Santos M. J., Imanaka T., Shio H., Small G. M., Lazarow P. B. Peroxisomal membrane ghosts in Zellweger syndrome--aberrant organelle assembly. Science. 1988 Mar 25;239(4847):1536–1538. doi: 10.1126/science.3281254. [DOI] [PubMed] [Google Scholar]
  19. Shimozawa N., Tsukamoto T., Suzuki Y., Orii T., Shirayoshi Y., Mori T., Fujiki Y. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science. 1992 Feb 28;255(5048):1132–1134. doi: 10.1126/science.1546315. [DOI] [PubMed] [Google Scholar]
  20. Suzuki Y., Shimozawa N., Yajima S., Orii T., Yokota S., Tashiro Y., Osumi T., Hashimoto T. Different intracellular localization of peroxisomal proteins in fibroblasts from patients with aberrant peroxisome assembly. Cell Struct Funct. 1992 Feb;17(1):1–8. doi: 10.1247/csf.17.1. [DOI] [PubMed] [Google Scholar]
  21. Swinkels B. W., Gould S. J., Bodnar A. G., Rachubinski R. A., Subramani S. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 1991 Nov;10(11):3255–3262. doi: 10.1002/j.1460-2075.1991.tb04889.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Swinkels B. W., Gould S. J., Subramani S. Targeting efficiencies of various permutations of the consensus C-terminal tripeptide peroxisomal targeting signal. FEBS Lett. 1992 Jun 29;305(2):133–136. doi: 10.1016/0014-5793(92)80880-p. [DOI] [PubMed] [Google Scholar]
  23. Walton P. A., Gould S. J., Feramisco J. R., Subramani S. Transport of microinjected proteins into peroxisomes of mammalian cells: inability of Zellweger cell lines to import proteins with the SKL tripeptide peroxisomal targeting signal. Mol Cell Biol. 1992 Feb;12(2):531–541. doi: 10.1128/mcb.12.2.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wendland M., Subramani S. Cytosol-dependent peroxisomal protein import in a permeabilized cell system. J Cell Biol. 1993 Feb;120(3):675–685. doi: 10.1083/jcb.120.3.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wiemer E. A., Brul S., Just W. W., Van Driel R., Brouwer-Kelder E., Van Den Berg M., Weijers P. J., Schutgens R. B., Van Den Bosch H., Schram A. Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts. Eur J Cell Biol. 1989 Dec;50(2):407–417. [PubMed] [Google Scholar]
  26. Wiemer E. A., Out M., Schelen A., Wanders R. J., Schutgens R. B., Van den Bosch H., Tager J. M. Phenotypic heterogeneity in cultured skin fibroblasts from patients with disorders of peroxisome biogenesis belonging to the same complementation group. Biochim Biophys Acta. 1991 Oct 21;1097(3):232–237. doi: 10.1016/0925-4439(91)90041-7. [DOI] [PubMed] [Google Scholar]
  27. Yajima S., Suzuki Y., Shimozawa N., Yamaguchi S., Orii T., Fujiki Y., Osumi T., Hashimoto T., Moser H. W. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet. 1992 Mar;88(5):491–499. doi: 10.1007/BF00219334. [DOI] [PubMed] [Google Scholar]
  28. de Hoop M. J., Ab G. Import of proteins into peroxisomes and other microbodies. Biochem J. 1992 Sep 15;286(Pt 3):657–669. doi: 10.1042/bj2860657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Roermund C. W., Brul S., Tager J. M., Schutgens R. B., Wanders R. J. Acyl-CoA oxidase, peroxisomal thiolase and dihydroxyacetone phosphate acyltransferase: aberrant subcellular localization in Zellweger syndrome. J Inherit Metab Dis. 1991;14(2):152–164. doi: 10.1007/BF01800588. [DOI] [PubMed] [Google Scholar]
  30. van den Bosch H., Schutgens R. B., Wanders R. J., Tager J. M. Biochemistry of peroxisomes. Annu Rev Biochem. 1992;61:157–197. doi: 10.1146/annurev.bi.61.070192.001105. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES